Global Iodinated Contrast Media in Interventional X-Ray Market Growth 2026-2032
The global Iodinated Contrast Media in Interventional X-Ray market size is predicted to grow from US$ 1761 million in 2025 to US$ 2635 million in 2032; it is expected to grow at a CAGR of 5.9% from 2026 to 2032.
In 2025, global Iodinated Contrast Media in Interventional X-Ray production reached approximately 4,000 K Litres, with an average global market price of around 450 US$/L.
Iodinated Contrast Media in Interventional X-Ray refers to organic iodine-containing compounds specifically used in interventional X-ray procedures, which enhance the visibility of internal blood vessels, tissues and lesions by absorbing X-rays, helping doctors clearly observe the anatomical structure and pathological state of target areas, guide interventional operations accurately, and evaluate the effect of interventional treatment, with good biocompatibility and rapid excretion characteristics to ensure the safety of clinical applications.
The demand for Iodinated Contrast Media in Interventional X-Ray is driven by the increasing prevalence of chronic diseases, the growing popularity of interventional X-ray technologies in clinical practice, and the continuous improvement of medical infrastructure, especially the rising application demand in cardiovascular and oncology interventional treatments; business opportunities lie in the R&D and promotion of low-osmolar, low-nephrotoxic and environment-friendly products, the acceleration of domestic substitution to break the monopoly of international manufacturers, and the expansion of market demand in emerging regions with the popularization of interventional medical services.
LP Information, Inc. (LPI) ' newest research report, the “Iodinated Contrast Media in Interventional X-Ray Industry Forecast” looks at past sales and reviews total world Iodinated Contrast Media in Interventional X-Ray sales in 2025, providing a comprehensive analysis by region and market sector of projected Iodinated Contrast Media in Interventional X-Ray sales for 2026 through 2032. With Iodinated Contrast Media in Interventional X-Ray sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Iodinated Contrast Media in Interventional X-Ray industry.
This Insight Report provides a comprehensive analysis of the global Iodinated Contrast Media in Interventional X-Ray landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Iodinated Contrast Media in Interventional X-Ray portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Iodinated Contrast Media in Interventional X-Ray market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Iodinated Contrast Media in Interventional X-Ray and breaks down the forecast by Chemical Structure, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Iodinated Contrast Media in Interventional X-Ray.
This report presents a comprehensive overview, market shares, and growth opportunities of Iodinated Contrast Media in Interventional X-Ray market by product type, application, key manufacturers and key regions and countries.
Segmentation by Chemical Structure:
What is the 10-year outlook for the global Iodinated Contrast Media in Interventional X-Ray market?
What factors are driving Iodinated Contrast Media in Interventional X-Ray market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Iodinated Contrast Media in Interventional X-Ray market opportunities vary by end market size?
How does Iodinated Contrast Media in Interventional X-Ray break out by Chemical Structure, by Application?
In 2025, global Iodinated Contrast Media in Interventional X-Ray production reached approximately 4,000 K Litres, with an average global market price of around 450 US$/L.
Iodinated Contrast Media in Interventional X-Ray refers to organic iodine-containing compounds specifically used in interventional X-ray procedures, which enhance the visibility of internal blood vessels, tissues and lesions by absorbing X-rays, helping doctors clearly observe the anatomical structure and pathological state of target areas, guide interventional operations accurately, and evaluate the effect of interventional treatment, with good biocompatibility and rapid excretion characteristics to ensure the safety of clinical applications.
The demand for Iodinated Contrast Media in Interventional X-Ray is driven by the increasing prevalence of chronic diseases, the growing popularity of interventional X-ray technologies in clinical practice, and the continuous improvement of medical infrastructure, especially the rising application demand in cardiovascular and oncology interventional treatments; business opportunities lie in the R&D and promotion of low-osmolar, low-nephrotoxic and environment-friendly products, the acceleration of domestic substitution to break the monopoly of international manufacturers, and the expansion of market demand in emerging regions with the popularization of interventional medical services.
LP Information, Inc. (LPI) ' newest research report, the “Iodinated Contrast Media in Interventional X-Ray Industry Forecast” looks at past sales and reviews total world Iodinated Contrast Media in Interventional X-Ray sales in 2025, providing a comprehensive analysis by region and market sector of projected Iodinated Contrast Media in Interventional X-Ray sales for 2026 through 2032. With Iodinated Contrast Media in Interventional X-Ray sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Iodinated Contrast Media in Interventional X-Ray industry.
This Insight Report provides a comprehensive analysis of the global Iodinated Contrast Media in Interventional X-Ray landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Iodinated Contrast Media in Interventional X-Ray portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Iodinated Contrast Media in Interventional X-Ray market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Iodinated Contrast Media in Interventional X-Ray and breaks down the forecast by Chemical Structure, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Iodinated Contrast Media in Interventional X-Ray.
This report presents a comprehensive overview, market shares, and growth opportunities of Iodinated Contrast Media in Interventional X-Ray market by product type, application, key manufacturers and key regions and countries.
Segmentation by Chemical Structure:
- Ionic Iodinated Contrast Media
- Non-Ionic Iodinated Contrast Media
- High-Osmolar Iodinated Contrast Media
- Low-Osmolar Iodinated Contrast Media
- Iso-Osmolar Iodinated Contrast Media
- Intravenous Iodinated Contrast Media
- Intra-Arterial Iodinated Contrast Media
- Hospitals
- Research Institutes
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bayer
- GE Healthcare
- Bracco Imaging
- Guerbet Group
- Novalek Pharmaceuticals
- Taejoon
- Unijules Life Sciences
- JB Pharma
- Hengrui Medicine
- YRPG
- BeiLu Pharma
- Sanochemia
- Imax
- CHIA TAI TIANQING
What is the 10-year outlook for the global Iodinated Contrast Media in Interventional X-Ray market?
What factors are driving Iodinated Contrast Media in Interventional X-Ray market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Iodinated Contrast Media in Interventional X-Ray market opportunities vary by end market size?
How does Iodinated Contrast Media in Interventional X-Ray break out by Chemical Structure, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Iodinated Contrast Media in Interventional X-Ray Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Iodinated Contrast Media in Interventional X-Ray by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Iodinated Contrast Media in Interventional X-Ray by Country/Region, 2021, 2025 & 2032
2.2 Iodinated Contrast Media in Interventional X-Ray Segment by Chemical Structure
2.2.1 Ionic Iodinated Contrast Media
2.2.2 Non-Ionic Iodinated Contrast Media
2.2.3 Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure
2.2.3.1 Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure (2021-2026)
2.2.3.2 Global Iodinated Contrast Media in Interventional X-Ray Revenue and Market Share by Chemical Structure (2021-2026)
2.2.3.3 Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Chemical Structure (2021-2026)
2.3 Iodinated Contrast Media in Interventional X-Ray Segment by Osmolarity
2.3.1 High-Osmolar Iodinated Contrast Media
2.3.2 Low-Osmolar Iodinated Contrast Media
2.3.3 Iso-Osmolar Iodinated Contrast Media
2.3.4 Iodinated Contrast Media in Interventional X-Ray Sales by Osmolarity
2.3.4.1 Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Osmolarity (2021-2026)
2.3.4.2 Global Iodinated Contrast Media in Interventional X-Ray Revenue and Market Share by Osmolarity (2021-2026)
2.3.4.3 Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Osmolarity (2021-2026)
2.4 Iodinated Contrast Media in Interventional X-Ray Segment by Administration Route
2.4.1 Intravenous Iodinated Contrast Media
2.4.2 Intra-Arterial Iodinated Contrast Media
2.4.3 Iodinated Contrast Media in Interventional X-Ray Sales by Administration Route
2.4.3.1 Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Administration Route (2021-2026)
2.4.3.2 Global Iodinated Contrast Media in Interventional X-Ray Revenue and Market Share by Administration Route (2021-2026)
2.4.3.3 Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Administration Route (2021-2026)
2.5 Iodinated Contrast Media in Interventional X-Ray Segment by Application
2.5.1 Hospitals
2.5.2 Research Institutes
2.5.3 Others
2.5.4 Iodinated Contrast Media in Interventional X-Ray Sales by Application
2.5.4.1 Global Iodinated Contrast Media in Interventional X-Ray Sale Market Share by Application (2021-2026)
2.5.4.2 Global Iodinated Contrast Media in Interventional X-Ray Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Iodinated Contrast Media in Interventional X-Ray Breakdown Data by Company
3.1.1 Global Iodinated Contrast Media in Interventional X-Ray Annual Sales by Company (2021-2026)
3.1.2 Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Company (2021-2026)
3.2 Global Iodinated Contrast Media in Interventional X-Ray Annual Revenue by Company (2021-2026)
3.2.1 Global Iodinated Contrast Media in Interventional X-Ray Revenue by Company (2021-2026)
3.2.2 Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Company (2021-2026)
3.3 Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Company
3.4 Key Manufacturers Iodinated Contrast Media in Interventional X-Ray Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Iodinated Contrast Media in Interventional X-Ray Product Location Distribution
3.4.2 Players Iodinated Contrast Media in Interventional X-Ray Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY BY GEOGRAPHIC REGION
4.1 World Historic Iodinated Contrast Media in Interventional X-Ray Market Size by Geographic Region (2021-2026)
4.1.1 Global Iodinated Contrast Media in Interventional X-Ray Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Iodinated Contrast Media in Interventional X-Ray Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Iodinated Contrast Media in Interventional X-Ray Market Size by Country/Region (2021-2026)
4.2.1 Global Iodinated Contrast Media in Interventional X-Ray Annual Sales by Country/Region (2021-2026)
4.2.2 Global Iodinated Contrast Media in Interventional X-Ray Annual Revenue by Country/Region (2021-2026)
4.3 Americas Iodinated Contrast Media in Interventional X-Ray Sales Growth
4.4 APAC Iodinated Contrast Media in Interventional X-Ray Sales Growth
4.5 Europe Iodinated Contrast Media in Interventional X-Ray Sales Growth
4.6 Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales Growth
5 AMERICAS
5.1 Americas Iodinated Contrast Media in Interventional X-Ray Sales by Country
5.1.1 Americas Iodinated Contrast Media in Interventional X-Ray Sales by Country (2021-2026)
5.1.2 Americas Iodinated Contrast Media in Interventional X-Ray Revenue by Country (2021-2026)
5.2 Americas Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026)
5.3 Americas Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Iodinated Contrast Media in Interventional X-Ray Sales by Region
6.1.1 APAC Iodinated Contrast Media in Interventional X-Ray Sales by Region (2021-2026)
6.1.2 APAC Iodinated Contrast Media in Interventional X-Ray Revenue by Region (2021-2026)
6.2 APAC Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026)
6.3 APAC Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Iodinated Contrast Media in Interventional X-Ray by Country
7.1.1 Europe Iodinated Contrast Media in Interventional X-Ray Sales by Country (2021-2026)
7.1.2 Europe Iodinated Contrast Media in Interventional X-Ray Revenue by Country (2021-2026)
7.2 Europe Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026)
7.3 Europe Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Iodinated Contrast Media in Interventional X-Ray by Country
8.1.1 Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales by Country (2021-2026)
8.1.2 Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Revenue by Country (2021-2026)
8.2 Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026)
8.3 Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Iodinated Contrast Media in Interventional X-Ray
10.3 Manufacturing Process Analysis of Iodinated Contrast Media in Interventional X-Ray
10.4 Industry Chain Structure of Iodinated Contrast Media in Interventional X-Ray
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Iodinated Contrast Media in Interventional X-Ray Distributors
11.3 Iodinated Contrast Media in Interventional X-Ray Customer
12 WORLD FORECAST REVIEW FOR IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY BY GEOGRAPHIC REGION
12.1 Global Iodinated Contrast Media in Interventional X-Ray Market Size Forecast by Region
12.1.1 Global Iodinated Contrast Media in Interventional X-Ray Forecast by Region (2027-2032)
12.1.2 Global Iodinated Contrast Media in Interventional X-Ray Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Iodinated Contrast Media in Interventional X-Ray Forecast by Chemical Structure (2027-2032)
12.7 Global Iodinated Contrast Media in Interventional X-Ray Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.1.3 Bayer Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.2.3 GE Healthcare Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Bracco Imaging
13.3.1 Bracco Imaging Company Information
13.3.2 Bracco Imaging Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.3.3 Bracco Imaging Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bracco Imaging Main Business Overview
13.3.5 Bracco Imaging Latest Developments
13.4 Guerbet Group
13.4.1 Guerbet Group Company Information
13.4.2 Guerbet Group Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.4.3 Guerbet Group Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Guerbet Group Main Business Overview
13.4.5 Guerbet Group Latest Developments
13.5 Novalek Pharmaceuticals
13.5.1 Novalek Pharmaceuticals Company Information
13.5.2 Novalek Pharmaceuticals Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.5.3 Novalek Pharmaceuticals Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Novalek Pharmaceuticals Main Business Overview
13.5.5 Novalek Pharmaceuticals Latest Developments
13.6 Taejoon
13.6.1 Taejoon Company Information
13.6.2 Taejoon Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.6.3 Taejoon Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Taejoon Main Business Overview
13.6.5 Taejoon Latest Developments
13.7 Unijules Life Sciences
13.7.1 Unijules Life Sciences Company Information
13.7.2 Unijules Life Sciences Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.7.3 Unijules Life Sciences Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Unijules Life Sciences Main Business Overview
13.7.5 Unijules Life Sciences Latest Developments
13.8 JB Pharma
13.8.1 JB Pharma Company Information
13.8.2 JB Pharma Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.8.3 JB Pharma Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 JB Pharma Main Business Overview
13.8.5 JB Pharma Latest Developments
13.9 Hengrui Medicine
13.9.1 Hengrui Medicine Company Information
13.9.2 Hengrui Medicine Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.9.3 Hengrui Medicine Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hengrui Medicine Main Business Overview
13.9.5 Hengrui Medicine Latest Developments
13.10 YRPG
13.10.1 YRPG Company Information
13.10.2 YRPG Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.10.3 YRPG Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 YRPG Main Business Overview
13.10.5 YRPG Latest Developments
13.11 BeiLu Pharma
13.11.1 BeiLu Pharma Company Information
13.11.2 BeiLu Pharma Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.11.3 BeiLu Pharma Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 BeiLu Pharma Main Business Overview
13.11.5 BeiLu Pharma Latest Developments
13.12 Sanochemia
13.12.1 Sanochemia Company Information
13.12.2 Sanochemia Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.12.3 Sanochemia Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sanochemia Main Business Overview
13.12.5 Sanochemia Latest Developments
13.13 Imax
13.13.1 Imax Company Information
13.13.2 Imax Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.13.3 Imax Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Imax Main Business Overview
13.13.5 Imax Latest Developments
13.14 CHIA TAI TIANQING
13.14.1 CHIA TAI TIANQING Company Information
13.14.2 CHIA TAI TIANQING Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.14.3 CHIA TAI TIANQING Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 CHIA TAI TIANQING Main Business Overview
13.14.5 CHIA TAI TIANQING Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Iodinated Contrast Media in Interventional X-Ray Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Iodinated Contrast Media in Interventional X-Ray by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Iodinated Contrast Media in Interventional X-Ray by Country/Region, 2021, 2025 & 2032
2.2 Iodinated Contrast Media in Interventional X-Ray Segment by Chemical Structure
2.2.1 Ionic Iodinated Contrast Media
2.2.2 Non-Ionic Iodinated Contrast Media
2.2.3 Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure
2.2.3.1 Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure (2021-2026)
2.2.3.2 Global Iodinated Contrast Media in Interventional X-Ray Revenue and Market Share by Chemical Structure (2021-2026)
2.2.3.3 Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Chemical Structure (2021-2026)
2.3 Iodinated Contrast Media in Interventional X-Ray Segment by Osmolarity
2.3.1 High-Osmolar Iodinated Contrast Media
2.3.2 Low-Osmolar Iodinated Contrast Media
2.3.3 Iso-Osmolar Iodinated Contrast Media
2.3.4 Iodinated Contrast Media in Interventional X-Ray Sales by Osmolarity
2.3.4.1 Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Osmolarity (2021-2026)
2.3.4.2 Global Iodinated Contrast Media in Interventional X-Ray Revenue and Market Share by Osmolarity (2021-2026)
2.3.4.3 Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Osmolarity (2021-2026)
2.4 Iodinated Contrast Media in Interventional X-Ray Segment by Administration Route
2.4.1 Intravenous Iodinated Contrast Media
2.4.2 Intra-Arterial Iodinated Contrast Media
2.4.3 Iodinated Contrast Media in Interventional X-Ray Sales by Administration Route
2.4.3.1 Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Administration Route (2021-2026)
2.4.3.2 Global Iodinated Contrast Media in Interventional X-Ray Revenue and Market Share by Administration Route (2021-2026)
2.4.3.3 Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Administration Route (2021-2026)
2.5 Iodinated Contrast Media in Interventional X-Ray Segment by Application
2.5.1 Hospitals
2.5.2 Research Institutes
2.5.3 Others
2.5.4 Iodinated Contrast Media in Interventional X-Ray Sales by Application
2.5.4.1 Global Iodinated Contrast Media in Interventional X-Ray Sale Market Share by Application (2021-2026)
2.5.4.2 Global Iodinated Contrast Media in Interventional X-Ray Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Iodinated Contrast Media in Interventional X-Ray Breakdown Data by Company
3.1.1 Global Iodinated Contrast Media in Interventional X-Ray Annual Sales by Company (2021-2026)
3.1.2 Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Company (2021-2026)
3.2 Global Iodinated Contrast Media in Interventional X-Ray Annual Revenue by Company (2021-2026)
3.2.1 Global Iodinated Contrast Media in Interventional X-Ray Revenue by Company (2021-2026)
3.2.2 Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Company (2021-2026)
3.3 Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Company
3.4 Key Manufacturers Iodinated Contrast Media in Interventional X-Ray Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Iodinated Contrast Media in Interventional X-Ray Product Location Distribution
3.4.2 Players Iodinated Contrast Media in Interventional X-Ray Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY BY GEOGRAPHIC REGION
4.1 World Historic Iodinated Contrast Media in Interventional X-Ray Market Size by Geographic Region (2021-2026)
4.1.1 Global Iodinated Contrast Media in Interventional X-Ray Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Iodinated Contrast Media in Interventional X-Ray Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Iodinated Contrast Media in Interventional X-Ray Market Size by Country/Region (2021-2026)
4.2.1 Global Iodinated Contrast Media in Interventional X-Ray Annual Sales by Country/Region (2021-2026)
4.2.2 Global Iodinated Contrast Media in Interventional X-Ray Annual Revenue by Country/Region (2021-2026)
4.3 Americas Iodinated Contrast Media in Interventional X-Ray Sales Growth
4.4 APAC Iodinated Contrast Media in Interventional X-Ray Sales Growth
4.5 Europe Iodinated Contrast Media in Interventional X-Ray Sales Growth
4.6 Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales Growth
5 AMERICAS
5.1 Americas Iodinated Contrast Media in Interventional X-Ray Sales by Country
5.1.1 Americas Iodinated Contrast Media in Interventional X-Ray Sales by Country (2021-2026)
5.1.2 Americas Iodinated Contrast Media in Interventional X-Ray Revenue by Country (2021-2026)
5.2 Americas Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026)
5.3 Americas Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Iodinated Contrast Media in Interventional X-Ray Sales by Region
6.1.1 APAC Iodinated Contrast Media in Interventional X-Ray Sales by Region (2021-2026)
6.1.2 APAC Iodinated Contrast Media in Interventional X-Ray Revenue by Region (2021-2026)
6.2 APAC Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026)
6.3 APAC Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Iodinated Contrast Media in Interventional X-Ray by Country
7.1.1 Europe Iodinated Contrast Media in Interventional X-Ray Sales by Country (2021-2026)
7.1.2 Europe Iodinated Contrast Media in Interventional X-Ray Revenue by Country (2021-2026)
7.2 Europe Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026)
7.3 Europe Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Iodinated Contrast Media in Interventional X-Ray by Country
8.1.1 Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales by Country (2021-2026)
8.1.2 Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Revenue by Country (2021-2026)
8.2 Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026)
8.3 Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Iodinated Contrast Media in Interventional X-Ray
10.3 Manufacturing Process Analysis of Iodinated Contrast Media in Interventional X-Ray
10.4 Industry Chain Structure of Iodinated Contrast Media in Interventional X-Ray
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Iodinated Contrast Media in Interventional X-Ray Distributors
11.3 Iodinated Contrast Media in Interventional X-Ray Customer
12 WORLD FORECAST REVIEW FOR IODINATED CONTRAST MEDIA IN INTERVENTIONAL X-RAY BY GEOGRAPHIC REGION
12.1 Global Iodinated Contrast Media in Interventional X-Ray Market Size Forecast by Region
12.1.1 Global Iodinated Contrast Media in Interventional X-Ray Forecast by Region (2027-2032)
12.1.2 Global Iodinated Contrast Media in Interventional X-Ray Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Iodinated Contrast Media in Interventional X-Ray Forecast by Chemical Structure (2027-2032)
12.7 Global Iodinated Contrast Media in Interventional X-Ray Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.1.3 Bayer Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 GE Healthcare
13.2.1 GE Healthcare Company Information
13.2.2 GE Healthcare Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.2.3 GE Healthcare Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GE Healthcare Main Business Overview
13.2.5 GE Healthcare Latest Developments
13.3 Bracco Imaging
13.3.1 Bracco Imaging Company Information
13.3.2 Bracco Imaging Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.3.3 Bracco Imaging Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bracco Imaging Main Business Overview
13.3.5 Bracco Imaging Latest Developments
13.4 Guerbet Group
13.4.1 Guerbet Group Company Information
13.4.2 Guerbet Group Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.4.3 Guerbet Group Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Guerbet Group Main Business Overview
13.4.5 Guerbet Group Latest Developments
13.5 Novalek Pharmaceuticals
13.5.1 Novalek Pharmaceuticals Company Information
13.5.2 Novalek Pharmaceuticals Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.5.3 Novalek Pharmaceuticals Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Novalek Pharmaceuticals Main Business Overview
13.5.5 Novalek Pharmaceuticals Latest Developments
13.6 Taejoon
13.6.1 Taejoon Company Information
13.6.2 Taejoon Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.6.3 Taejoon Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Taejoon Main Business Overview
13.6.5 Taejoon Latest Developments
13.7 Unijules Life Sciences
13.7.1 Unijules Life Sciences Company Information
13.7.2 Unijules Life Sciences Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.7.3 Unijules Life Sciences Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Unijules Life Sciences Main Business Overview
13.7.5 Unijules Life Sciences Latest Developments
13.8 JB Pharma
13.8.1 JB Pharma Company Information
13.8.2 JB Pharma Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.8.3 JB Pharma Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 JB Pharma Main Business Overview
13.8.5 JB Pharma Latest Developments
13.9 Hengrui Medicine
13.9.1 Hengrui Medicine Company Information
13.9.2 Hengrui Medicine Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.9.3 Hengrui Medicine Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Hengrui Medicine Main Business Overview
13.9.5 Hengrui Medicine Latest Developments
13.10 YRPG
13.10.1 YRPG Company Information
13.10.2 YRPG Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.10.3 YRPG Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 YRPG Main Business Overview
13.10.5 YRPG Latest Developments
13.11 BeiLu Pharma
13.11.1 BeiLu Pharma Company Information
13.11.2 BeiLu Pharma Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.11.3 BeiLu Pharma Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 BeiLu Pharma Main Business Overview
13.11.5 BeiLu Pharma Latest Developments
13.12 Sanochemia
13.12.1 Sanochemia Company Information
13.12.2 Sanochemia Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.12.3 Sanochemia Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Sanochemia Main Business Overview
13.12.5 Sanochemia Latest Developments
13.13 Imax
13.13.1 Imax Company Information
13.13.2 Imax Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.13.3 Imax Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Imax Main Business Overview
13.13.5 Imax Latest Developments
13.14 CHIA TAI TIANQING
13.14.1 CHIA TAI TIANQING Company Information
13.14.2 CHIA TAI TIANQING Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
13.14.3 CHIA TAI TIANQING Iodinated Contrast Media in Interventional X-Ray Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 CHIA TAI TIANQING Main Business Overview
13.14.5 CHIA TAI TIANQING Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Iodinated Contrast Media in Interventional X-Ray Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Iodinated Contrast Media in Interventional X-Ray Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Ionic Iodinated Contrast Media
Table 4. Major Players of Non-Ionic Iodinated Contrast Media
Table 5. Global Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026) & (K Litres)
Table 6. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure (2021-2026)
Table 7. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Chemical Structure (2021-2026) & ($ million)
Table 8. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Chemical Structure (2021-2026)
Table 9. Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Chemical Structure (2021-2026) & (US$/Litre)
Table 10. Major Players of High-Osmolar Iodinated Contrast Media
Table 11. Major Players of Low-Osmolar Iodinated Contrast Media
Table 12. Major Players of Iso-Osmolar Iodinated Contrast Media
Table 13. Global Iodinated Contrast Media in Interventional X-Ray Sales by Osmolarity (2021-2026) & (K Litres)
Table 14. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Osmolarity (2021-2026)
Table 15. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Osmolarity (2021-2026) & ($ million)
Table 16. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Osmolarity (2021-2026)
Table 17. Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Osmolarity (2021-2026) & (US$/Litre)
Table 18. Major Players of Intravenous Iodinated Contrast Media
Table 19. Major Players of Intra-Arterial Iodinated Contrast Media
Table 20. Global Iodinated Contrast Media in Interventional X-Ray Sales by Administration Route (2021-2026) & (K Litres)
Table 21. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Administration Route (2021-2026)
Table 22. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Administration Route (2021-2026) & ($ million)
Table 23. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Administration Route (2021-2026)
Table 24. Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Administration Route (2021-2026) & (US$/Litre)
Table 25. Global Iodinated Contrast Media in Interventional X-Ray Sale by Application (2021-2026) & (K Litres)
Table 26. Global Iodinated Contrast Media in Interventional X-Ray Sale Market Share by Application (2021-2026)
Table 27. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Application (2021-2026) & ($ million)
Table 28. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Application (2021-2026)
Table 29. Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Application (2021-2026) & (US$/Litre)
Table 30. Global Iodinated Contrast Media in Interventional X-Ray Sales by Company (2021-2026) & (K Litres)
Table 31. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Company (2021-2026)
Table 32. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Company (2021-2026)
Table 34. Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Company (2021-2026) & (US$/Litre)
Table 35. Key Manufacturers Iodinated Contrast Media in Interventional X-Ray Producing Area Distribution and Sales Area
Table 36. Players Iodinated Contrast Media in Interventional X-Ray Products Offered
Table 37. Iodinated Contrast Media in Interventional X-Ray Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Iodinated Contrast Media in Interventional X-Ray Sales by Geographic Region (2021-2026) & (K Litres)
Table 41. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share Geographic Region (2021-2026)
Table 42. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Iodinated Contrast Media in Interventional X-Ray Sales by Country/Region (2021-2026) & (K Litres)
Table 45. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country/Region (2021-2026)
Table 46. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Iodinated Contrast Media in Interventional X-Ray Sales by Country (2021-2026) & (K Litres)
Table 49. Americas Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country (2021-2026)
Table 50. Americas Iodinated Contrast Media in Interventional X-Ray Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026) & (K Litres)
Table 52. Americas Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026) & (K Litres)
Table 53. APAC Iodinated Contrast Media in Interventional X-Ray Sales by Region (2021-2026) & (K Litres)
Table 54. APAC Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Region (2021-2026)
Table 55. APAC Iodinated Contrast Media in Interventional X-Ray Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026) & (K Litres)
Table 57. APAC Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026) & (K Litres)
Table 58. Europe Iodinated Contrast Media in Interventional X-Ray Sales by Country (2021-2026) & (K Litres)
Table 59. Europe Iodinated Contrast Media in Interventional X-Ray Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026) & (K Litres)
Table 61. Europe Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026) & (K Litres)
Table 62. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales by Country (2021-2026) & (K Litres)
Table 63. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026) & (K Litres)
Table 65. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026) & (K Litres)
Table 66. Key Market Drivers & Growth Opportunities of Iodinated Contrast Media in Interventional X-Ray
Table 67. Key Market Challenges & Risks of Iodinated Contrast Media in Interventional X-Ray
Table 68. Key Industry Trends of Iodinated Contrast Media in Interventional X-Ray
Table 69. Iodinated Contrast Media in Interventional X-Ray Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Iodinated Contrast Media in Interventional X-Ray Distributors List
Table 72. Iodinated Contrast Media in Interventional X-Ray Customer List
Table 73. Global Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Region (2027-2032) & (K Litres)
Table 74. Global Iodinated Contrast Media in Interventional X-Ray Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Country (2027-2032) & (K Litres)
Table 76. Americas Iodinated Contrast Media in Interventional X-Ray Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Region (2027-2032) & (K Litres)
Table 78. APAC Iodinated Contrast Media in Interventional X-Ray Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Country (2027-2032) & (K Litres)
Table 80. Europe Iodinated Contrast Media in Interventional X-Ray Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Country (2027-2032) & (K Litres)
Table 82. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Chemical Structure (2027-2032) & (K Litres)
Table 84. Global Iodinated Contrast Media in Interventional X-Ray Revenue Forecast by Chemical Structure (2027-2032) & ($ millions)
Table 85. Global Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Application (2027-2032) & (K Litres)
Table 86. Global Iodinated Contrast Media in Interventional X-Ray Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Bayer Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 88. Bayer Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 89. Bayer Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 90. Bayer Main Business
Table 91. Bayer Latest Developments
Table 92. GE Healthcare Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 93. GE Healthcare Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 94. GE Healthcare Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 95. GE Healthcare Main Business
Table 96. GE Healthcare Latest Developments
Table 97. Bracco Imaging Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 98. Bracco Imaging Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 99. Bracco Imaging Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 100. Bracco Imaging Main Business
Table 101. Bracco Imaging Latest Developments
Table 102. Guerbet Group Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 103. Guerbet Group Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 104. Guerbet Group Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 105. Guerbet Group Main Business
Table 106. Guerbet Group Latest Developments
Table 107. Novalek Pharmaceuticals Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 108. Novalek Pharmaceuticals Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 109. Novalek Pharmaceuticals Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 110. Novalek Pharmaceuticals Main Business
Table 111. Novalek Pharmaceuticals Latest Developments
Table 112. Taejoon Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 113. Taejoon Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 114. Taejoon Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 115. Taejoon Main Business
Table 116. Taejoon Latest Developments
Table 117. Unijules Life Sciences Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 118. Unijules Life Sciences Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 119. Unijules Life Sciences Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 120. Unijules Life Sciences Main Business
Table 121. Unijules Life Sciences Latest Developments
Table 122. JB Pharma Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 123. JB Pharma Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 124. JB Pharma Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 125. JB Pharma Main Business
Table 126. JB Pharma Latest Developments
Table 127. Hengrui Medicine Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 128. Hengrui Medicine Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 129. Hengrui Medicine Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 130. Hengrui Medicine Main Business
Table 131. Hengrui Medicine Latest Developments
Table 132. YRPG Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 133. YRPG Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 134. YRPG Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 135. YRPG Main Business
Table 136. YRPG Latest Developments
Table 137. BeiLu Pharma Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 138. BeiLu Pharma Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 139. BeiLu Pharma Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 140. BeiLu Pharma Main Business
Table 141. BeiLu Pharma Latest Developments
Table 142. Sanochemia Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 143. Sanochemia Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 144. Sanochemia Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 145. Sanochemia Main Business
Table 146. Sanochemia Latest Developments
Table 147. Imax Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 148. Imax Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 149. Imax Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 150. Imax Main Business
Table 151. Imax Latest Developments
Table 152. CHIA TAI TIANQING Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 153. CHIA TAI TIANQING Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 154. CHIA TAI TIANQING Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 155. CHIA TAI TIANQING Main Business
Table 156. CHIA TAI TIANQING Latest Developments
Table 1. Iodinated Contrast Media in Interventional X-Ray Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Iodinated Contrast Media in Interventional X-Ray Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Ionic Iodinated Contrast Media
Table 4. Major Players of Non-Ionic Iodinated Contrast Media
Table 5. Global Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026) & (K Litres)
Table 6. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure (2021-2026)
Table 7. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Chemical Structure (2021-2026) & ($ million)
Table 8. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Chemical Structure (2021-2026)
Table 9. Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Chemical Structure (2021-2026) & (US$/Litre)
Table 10. Major Players of High-Osmolar Iodinated Contrast Media
Table 11. Major Players of Low-Osmolar Iodinated Contrast Media
Table 12. Major Players of Iso-Osmolar Iodinated Contrast Media
Table 13. Global Iodinated Contrast Media in Interventional X-Ray Sales by Osmolarity (2021-2026) & (K Litres)
Table 14. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Osmolarity (2021-2026)
Table 15. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Osmolarity (2021-2026) & ($ million)
Table 16. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Osmolarity (2021-2026)
Table 17. Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Osmolarity (2021-2026) & (US$/Litre)
Table 18. Major Players of Intravenous Iodinated Contrast Media
Table 19. Major Players of Intra-Arterial Iodinated Contrast Media
Table 20. Global Iodinated Contrast Media in Interventional X-Ray Sales by Administration Route (2021-2026) & (K Litres)
Table 21. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Administration Route (2021-2026)
Table 22. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Administration Route (2021-2026) & ($ million)
Table 23. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Administration Route (2021-2026)
Table 24. Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Administration Route (2021-2026) & (US$/Litre)
Table 25. Global Iodinated Contrast Media in Interventional X-Ray Sale by Application (2021-2026) & (K Litres)
Table 26. Global Iodinated Contrast Media in Interventional X-Ray Sale Market Share by Application (2021-2026)
Table 27. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Application (2021-2026) & ($ million)
Table 28. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Application (2021-2026)
Table 29. Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Application (2021-2026) & (US$/Litre)
Table 30. Global Iodinated Contrast Media in Interventional X-Ray Sales by Company (2021-2026) & (K Litres)
Table 31. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Company (2021-2026)
Table 32. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Company (2021-2026) & ($ millions)
Table 33. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Company (2021-2026)
Table 34. Global Iodinated Contrast Media in Interventional X-Ray Sale Price by Company (2021-2026) & (US$/Litre)
Table 35. Key Manufacturers Iodinated Contrast Media in Interventional X-Ray Producing Area Distribution and Sales Area
Table 36. Players Iodinated Contrast Media in Interventional X-Ray Products Offered
Table 37. Iodinated Contrast Media in Interventional X-Ray Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 38. New Products and Potential Entrants
Table 39. Market M&A Activity & Strategy
Table 40. Global Iodinated Contrast Media in Interventional X-Ray Sales by Geographic Region (2021-2026) & (K Litres)
Table 41. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share Geographic Region (2021-2026)
Table 42. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Geographic Region (2021-2026) & ($ millions)
Table 43. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Geographic Region (2021-2026)
Table 44. Global Iodinated Contrast Media in Interventional X-Ray Sales by Country/Region (2021-2026) & (K Litres)
Table 45. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country/Region (2021-2026)
Table 46. Global Iodinated Contrast Media in Interventional X-Ray Revenue by Country/Region (2021-2026) & ($ millions)
Table 47. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Country/Region (2021-2026)
Table 48. Americas Iodinated Contrast Media in Interventional X-Ray Sales by Country (2021-2026) & (K Litres)
Table 49. Americas Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country (2021-2026)
Table 50. Americas Iodinated Contrast Media in Interventional X-Ray Revenue by Country (2021-2026) & ($ millions)
Table 51. Americas Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026) & (K Litres)
Table 52. Americas Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026) & (K Litres)
Table 53. APAC Iodinated Contrast Media in Interventional X-Ray Sales by Region (2021-2026) & (K Litres)
Table 54. APAC Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Region (2021-2026)
Table 55. APAC Iodinated Contrast Media in Interventional X-Ray Revenue by Region (2021-2026) & ($ millions)
Table 56. APAC Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026) & (K Litres)
Table 57. APAC Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026) & (K Litres)
Table 58. Europe Iodinated Contrast Media in Interventional X-Ray Sales by Country (2021-2026) & (K Litres)
Table 59. Europe Iodinated Contrast Media in Interventional X-Ray Revenue by Country (2021-2026) & ($ millions)
Table 60. Europe Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026) & (K Litres)
Table 61. Europe Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026) & (K Litres)
Table 62. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales by Country (2021-2026) & (K Litres)
Table 63. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Country (2021-2026)
Table 64. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales by Chemical Structure (2021-2026) & (K Litres)
Table 65. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales by Application (2021-2026) & (K Litres)
Table 66. Key Market Drivers & Growth Opportunities of Iodinated Contrast Media in Interventional X-Ray
Table 67. Key Market Challenges & Risks of Iodinated Contrast Media in Interventional X-Ray
Table 68. Key Industry Trends of Iodinated Contrast Media in Interventional X-Ray
Table 69. Iodinated Contrast Media in Interventional X-Ray Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Iodinated Contrast Media in Interventional X-Ray Distributors List
Table 72. Iodinated Contrast Media in Interventional X-Ray Customer List
Table 73. Global Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Region (2027-2032) & (K Litres)
Table 74. Global Iodinated Contrast Media in Interventional X-Ray Revenue Forecast by Region (2027-2032) & ($ millions)
Table 75. Americas Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Country (2027-2032) & (K Litres)
Table 76. Americas Iodinated Contrast Media in Interventional X-Ray Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 77. APAC Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Region (2027-2032) & (K Litres)
Table 78. APAC Iodinated Contrast Media in Interventional X-Ray Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 79. Europe Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Country (2027-2032) & (K Litres)
Table 80. Europe Iodinated Contrast Media in Interventional X-Ray Revenue Forecast by Country (2027-2032) & ($ millions)
Table 81. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Country (2027-2032) & (K Litres)
Table 82. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Global Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Chemical Structure (2027-2032) & (K Litres)
Table 84. Global Iodinated Contrast Media in Interventional X-Ray Revenue Forecast by Chemical Structure (2027-2032) & ($ millions)
Table 85. Global Iodinated Contrast Media in Interventional X-Ray Sales Forecast by Application (2027-2032) & (K Litres)
Table 86. Global Iodinated Contrast Media in Interventional X-Ray Revenue Forecast by Application (2027-2032) & ($ millions)
Table 87. Bayer Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 88. Bayer Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 89. Bayer Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 90. Bayer Main Business
Table 91. Bayer Latest Developments
Table 92. GE Healthcare Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 93. GE Healthcare Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 94. GE Healthcare Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 95. GE Healthcare Main Business
Table 96. GE Healthcare Latest Developments
Table 97. Bracco Imaging Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 98. Bracco Imaging Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 99. Bracco Imaging Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 100. Bracco Imaging Main Business
Table 101. Bracco Imaging Latest Developments
Table 102. Guerbet Group Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 103. Guerbet Group Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 104. Guerbet Group Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 105. Guerbet Group Main Business
Table 106. Guerbet Group Latest Developments
Table 107. Novalek Pharmaceuticals Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 108. Novalek Pharmaceuticals Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 109. Novalek Pharmaceuticals Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 110. Novalek Pharmaceuticals Main Business
Table 111. Novalek Pharmaceuticals Latest Developments
Table 112. Taejoon Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 113. Taejoon Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 114. Taejoon Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 115. Taejoon Main Business
Table 116. Taejoon Latest Developments
Table 117. Unijules Life Sciences Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 118. Unijules Life Sciences Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 119. Unijules Life Sciences Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 120. Unijules Life Sciences Main Business
Table 121. Unijules Life Sciences Latest Developments
Table 122. JB Pharma Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 123. JB Pharma Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 124. JB Pharma Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 125. JB Pharma Main Business
Table 126. JB Pharma Latest Developments
Table 127. Hengrui Medicine Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 128. Hengrui Medicine Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 129. Hengrui Medicine Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 130. Hengrui Medicine Main Business
Table 131. Hengrui Medicine Latest Developments
Table 132. YRPG Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 133. YRPG Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 134. YRPG Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 135. YRPG Main Business
Table 136. YRPG Latest Developments
Table 137. BeiLu Pharma Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 138. BeiLu Pharma Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 139. BeiLu Pharma Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 140. BeiLu Pharma Main Business
Table 141. BeiLu Pharma Latest Developments
Table 142. Sanochemia Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 143. Sanochemia Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 144. Sanochemia Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 145. Sanochemia Main Business
Table 146. Sanochemia Latest Developments
Table 147. Imax Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 148. Imax Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 149. Imax Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 150. Imax Main Business
Table 151. Imax Latest Developments
Table 152. CHIA TAI TIANQING Basic Information, Iodinated Contrast Media in Interventional X-Ray Manufacturing Base, Sales Area and Its Competitors
Table 153. CHIA TAI TIANQING Iodinated Contrast Media in Interventional X-Ray Product Portfolios and Specifications
Table 154. CHIA TAI TIANQING Iodinated Contrast Media in Interventional X-Ray Sales (K Litres), Revenue ($ Million), Price (US$/Litre) and Gross Margin (2021-2026)
Table 155. CHIA TAI TIANQING Main Business
Table 156. CHIA TAI TIANQING Latest Developments
LIST OF FIGURES
Figure 1. Picture of Iodinated Contrast Media in Interventional X-Ray
Figure 2. Iodinated Contrast Media in Interventional X-Ray Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Iodinated Contrast Media in Interventional X-Ray Sales Growth Rate 2021-2032 (K Litres)
Figure 7. Global Iodinated Contrast Media in Interventional X-Ray Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Iodinated Contrast Media in Interventional X-Ray Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country/Region (2025)
Figure 10. Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Ionic Iodinated Contrast Media
Figure 12. Product Picture of Non-Ionic Iodinated Contrast Media
Figure 13. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure in 2026
Figure 14. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Chemical Structure (2021-2026)
Figure 15. Product Picture of High-Osmolar Iodinated Contrast Media
Figure 16. Product Picture of Low-Osmolar Iodinated Contrast Media
Figure 17. Product Picture of Iso-Osmolar Iodinated Contrast Media
Figure 18. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Osmolarity in 2026
Figure 19. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Osmolarity (2021-2026)
Figure 20. Product Picture of Intravenous Iodinated Contrast Media
Figure 21. Product Picture of Intra-Arterial Iodinated Contrast Media
Figure 22. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Administration Route in 2026
Figure 23. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Administration Route (2021-2026)
Figure 24. Iodinated Contrast Media in Interventional X-Ray Consumed in Hospitals
Figure 25. Global Iodinated Contrast Media in Interventional X-Ray Market: Hospitals (2021-2026) & (K Litres)
Figure 26. Iodinated Contrast Media in Interventional X-Ray Consumed in Research Institutes
Figure 27. Global Iodinated Contrast Media in Interventional X-Ray Market: Research Institutes (2021-2026) & (K Litres)
Figure 28. Iodinated Contrast Media in Interventional X-Ray Consumed in Others
Figure 29. Global Iodinated Contrast Media in Interventional X-Ray Market: Others (2021-2026) & (K Litres)
Figure 30. Global Iodinated Contrast Media in Interventional X-Ray Sale Market Share by Application (2025)
Figure 31. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Application in 2025
Figure 32. Iodinated Contrast Media in Interventional X-Ray Sales by Company in 2025 (K Litres)
Figure 33. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Company in 2025
Figure 34. Iodinated Contrast Media in Interventional X-Ray Revenue by Company in 2025 ($ millions)
Figure 35. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Company in 2025
Figure 36. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Geographic Region in 2025
Figure 38. Americas Iodinated Contrast Media in Interventional X-Ray Sales 2021-2026 (K Litres)
Figure 39. Americas Iodinated Contrast Media in Interventional X-Ray Revenue 2021-2026 ($ millions)
Figure 40. APAC Iodinated Contrast Media in Interventional X-Ray Sales 2021-2026 (K Litres)
Figure 41. APAC Iodinated Contrast Media in Interventional X-Ray Revenue 2021-2026 ($ millions)
Figure 42. Europe Iodinated Contrast Media in Interventional X-Ray Sales 2021-2026 (K Litres)
Figure 43. Europe Iodinated Contrast Media in Interventional X-Ray Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales 2021-2026 (K Litres)
Figure 45. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Revenue 2021-2026 ($ millions)
Figure 46. Americas Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country in 2025
Figure 47. Americas Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Country (2021-2026)
Figure 48. Americas Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure (2021-2026)
Figure 49. Americas Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Application (2021-2026)
Figure 50. United States Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Region in 2025
Figure 55. APAC Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Region (2021-2026)
Figure 56. APAC Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure (2021-2026)
Figure 57. APAC Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Application (2021-2026)
Figure 58. China Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 62. India Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country in 2025
Figure 66. Europe Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Country (2021-2026)
Figure 67. Europe Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure (2021-2026)
Figure 68. Europe Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Application (2021-2026)
Figure 69. Germany Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 70. France Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure (2021-2026)
Figure 76. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Application (2021-2026)
Figure 77. Egypt Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Iodinated Contrast Media in Interventional X-Ray in 2026
Figure 83. Manufacturing Process Analysis of Iodinated Contrast Media in Interventional X-Ray
Figure 84. Industry Chain Structure of Iodinated Contrast Media in Interventional X-Ray
Figure 85. Channels of Distribution
Figure 86. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Forecast by Region (2027-2032)
Figure 87. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share Forecast by Chemical Structure (2027-2032)
Figure 89. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share Forecast by Chemical Structure (2027-2032)
Figure 90. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Iodinated Contrast Media in Interventional X-Ray
Figure 2. Iodinated Contrast Media in Interventional X-Ray Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Iodinated Contrast Media in Interventional X-Ray Sales Growth Rate 2021-2032 (K Litres)
Figure 7. Global Iodinated Contrast Media in Interventional X-Ray Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Iodinated Contrast Media in Interventional X-Ray Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country/Region (2025)
Figure 10. Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Ionic Iodinated Contrast Media
Figure 12. Product Picture of Non-Ionic Iodinated Contrast Media
Figure 13. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure in 2026
Figure 14. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Chemical Structure (2021-2026)
Figure 15. Product Picture of High-Osmolar Iodinated Contrast Media
Figure 16. Product Picture of Low-Osmolar Iodinated Contrast Media
Figure 17. Product Picture of Iso-Osmolar Iodinated Contrast Media
Figure 18. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Osmolarity in 2026
Figure 19. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Osmolarity (2021-2026)
Figure 20. Product Picture of Intravenous Iodinated Contrast Media
Figure 21. Product Picture of Intra-Arterial Iodinated Contrast Media
Figure 22. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Administration Route in 2026
Figure 23. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Administration Route (2021-2026)
Figure 24. Iodinated Contrast Media in Interventional X-Ray Consumed in Hospitals
Figure 25. Global Iodinated Contrast Media in Interventional X-Ray Market: Hospitals (2021-2026) & (K Litres)
Figure 26. Iodinated Contrast Media in Interventional X-Ray Consumed in Research Institutes
Figure 27. Global Iodinated Contrast Media in Interventional X-Ray Market: Research Institutes (2021-2026) & (K Litres)
Figure 28. Iodinated Contrast Media in Interventional X-Ray Consumed in Others
Figure 29. Global Iodinated Contrast Media in Interventional X-Ray Market: Others (2021-2026) & (K Litres)
Figure 30. Global Iodinated Contrast Media in Interventional X-Ray Sale Market Share by Application (2025)
Figure 31. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Application in 2025
Figure 32. Iodinated Contrast Media in Interventional X-Ray Sales by Company in 2025 (K Litres)
Figure 33. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Company in 2025
Figure 34. Iodinated Contrast Media in Interventional X-Ray Revenue by Company in 2025 ($ millions)
Figure 35. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Company in 2025
Figure 36. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Geographic Region (2021-2026)
Figure 37. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Geographic Region in 2025
Figure 38. Americas Iodinated Contrast Media in Interventional X-Ray Sales 2021-2026 (K Litres)
Figure 39. Americas Iodinated Contrast Media in Interventional X-Ray Revenue 2021-2026 ($ millions)
Figure 40. APAC Iodinated Contrast Media in Interventional X-Ray Sales 2021-2026 (K Litres)
Figure 41. APAC Iodinated Contrast Media in Interventional X-Ray Revenue 2021-2026 ($ millions)
Figure 42. Europe Iodinated Contrast Media in Interventional X-Ray Sales 2021-2026 (K Litres)
Figure 43. Europe Iodinated Contrast Media in Interventional X-Ray Revenue 2021-2026 ($ millions)
Figure 44. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales 2021-2026 (K Litres)
Figure 45. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Revenue 2021-2026 ($ millions)
Figure 46. Americas Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country in 2025
Figure 47. Americas Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Country (2021-2026)
Figure 48. Americas Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure (2021-2026)
Figure 49. Americas Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Application (2021-2026)
Figure 50. United States Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 51. Canada Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 52. Mexico Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 53. Brazil Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 54. APAC Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Region in 2025
Figure 55. APAC Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Region (2021-2026)
Figure 56. APAC Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure (2021-2026)
Figure 57. APAC Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Application (2021-2026)
Figure 58. China Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 59. Japan Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 60. South Korea Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 61. Southeast Asia Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 62. India Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 63. Australia Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 64. China Taiwan Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 65. Europe Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country in 2025
Figure 66. Europe Iodinated Contrast Media in Interventional X-Ray Revenue Market Share by Country (2021-2026)
Figure 67. Europe Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure (2021-2026)
Figure 68. Europe Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Application (2021-2026)
Figure 69. Germany Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 70. France Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 71. UK Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 72. Italy Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 73. Russia Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 74. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Country (2021-2026)
Figure 75. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Chemical Structure (2021-2026)
Figure 76. Middle East & Africa Iodinated Contrast Media in Interventional X-Ray Sales Market Share by Application (2021-2026)
Figure 77. Egypt Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 78. South Africa Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 79. Israel Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 80. Turkey Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 81. GCC Countries Iodinated Contrast Media in Interventional X-Ray Revenue Growth 2021-2026 ($ millions)
Figure 82. Manufacturing Cost Structure Analysis of Iodinated Contrast Media in Interventional X-Ray in 2026
Figure 83. Manufacturing Process Analysis of Iodinated Contrast Media in Interventional X-Ray
Figure 84. Industry Chain Structure of Iodinated Contrast Media in Interventional X-Ray
Figure 85. Channels of Distribution
Figure 86. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Forecast by Region (2027-2032)
Figure 87. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share Forecast by Region (2027-2032)
Figure 88. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share Forecast by Chemical Structure (2027-2032)
Figure 89. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share Forecast by Chemical Structure (2027-2032)
Figure 90. Global Iodinated Contrast Media in Interventional X-Ray Sales Market Share Forecast by Application (2027-2032)
Figure 91. Global Iodinated Contrast Media in Interventional X-Ray Revenue Market Share Forecast by Application (2027-2032)
